NeuraMetrix
Curated by SignalDeveloper of a non-invasive proprietary biomarker to treat and monitor a wide range of brain disorders
Overview
Developer of a non-invasive proprietary biomarker to treat and monitor a wide range of brain disorders. The platform helps to measure brain health using a digital bio-marker based on typing cadence enabling the detection of subtle changes in cognitive and motor function. It is applicable for therapeutic areas such as Alzheimer's disease, brain tumors, depression, Huntington's disease, Parkinson's disease, and REM sleep disorder.
Key facts
- Founded
- 2012
- Headquarters
- Palo Alto, United States
- Stage
- Sign up to view
- Industry
- Health Technology
Contact
- Primary office
- Sign up to view
- Sign up to view